[Angiotensin II antagonists: a distinct therapeutic class].
Angiotensin II antagonists are a promising new class of antihypertensive agents. Unlike angiotensin converting enzyme inhibitors, these new agents block the renin-angiotensin system by acting directly on the angiotensin II receptor. It is quite probable that these agents will become a first line therapeutic choice for hypertensive patients. Current clinical trials on primary prevention may confirm the indications for this new therapeutic class in a near feature.
Waeber
B
B
Brunner
H R
HR
D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D019808:Losartan; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D000804:Angiotensin II; D019808:Losartan
Les antagonistes de l'angiotensine II: une classe thérapeutique à part.